Erasca
eras phase responses observed in patients with ras and alterations in diverse tumor types with single agent schedule | Erasca
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
22 of 46
Similar slides by Erasca
See diffirences between slides (animation)
Investor Presentation
November 2023
eras phase responses observed in patients with ras and alterations in diverse tumor types with single agent schedule | Erasca
Investor Presentation
August 2023
eras phase responses observed in patients with ras and alterations in diverse tumor types with single agent schedule | Erasca
Related slides by other companies
BioAtla
Investor Presentation
November 2022
best response in phase non squamous patients | BioAtla
Kymera
Investor Presentation
August 2023
part summary | Kymera
Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Oculis
Investor Presentation
July 2023
towards the assessment of the efficacy of in patients phase acuity trial in acute optic neuritis | Oculis
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io